Paul McBarron
2018
In 2018, Paul McBarron earned a total compensation of $388K as Executive Vice President, Finance, Chief Operating Officer, Chief Financial Officer, Secretary at Cyclacel Pharmaceuticals, a 8% decrease compared to previous year.
Compensation breakdown
| Bonus | $60,163 |
|---|---|
| Option Awards | $41,203 |
| Salary | $266,504 |
| Other | $20,124 |
| Total | $387,994 |
McBarron received $266.5K in salary, accounting for 69% of the total pay in 2018.
McBarron also received $60.2K in bonus, $41.2K in option awards and $20.1K in other compensation.
Rankings
In 2018, Paul McBarron's compensation ranked 12,617th out of 14,244 executives tracked by ExecPay. In other words, McBarron earned more than 11.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 12,617 out of 14,244 | 11th |
Division Manufacturing | 5,106 out of 5,759 | 11th |
Major group Chemicals And Allied Products | 1,933 out of 2,122 | 9th |
Industry group Drugs | 1,656 out of 1,811 | 9th |
Industry Pharmaceutical Preparations | 1,266 out of 1,385 | 9th |
Source: SEC filing on May 12, 2020.
McBarron's colleagues
We found two more compensation records of executives who worked with Paul McBarron at Cyclacel Pharmaceuticals in 2018.
News
Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2023 pay slips 13% to $661K
May 7, 2024
Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2022 pay falls 43% to $764K
April 28, 2023
Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2021 pay slips 5% to $1.3M
April 26, 2022
Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2020 pay jumps 39% to $1.4M
April 29, 2021
Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2019 pay jumps 35% to $1M
May 12, 2020